Paid Clinical Trials in Brisbane, Queensland for Healthy Volunteers
Brisbane, Queensland has 6 clinical trials actively recruiting healthy volunteers. These include Phase 1 drug safety studies, bioequivalence trials, vaccine studies, and observational research — most offering financial compensation for participation. Learn which studies pay the most →
Showing 1–6 of 6 studies
Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers
Long-Term PEA Safety Study
A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers
A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects
Common questions about trials in Brisbane, Queensland
How many paid clinical trials are recruiting healthy volunteers in Brisbane, Queensland?
There are currently 6 clinical trials actively recruiting healthy volunteers in Brisbane, Queensland. This number updates daily as new studies open and existing studies complete enrollment.
How much do clinical trials pay in Brisbane, Queensland?
Compensation varies by study type and duration. Phase 1 inpatient studies typically pay $1,000–$5,000+, outpatient visits may pay $50–$500 each, and bioequivalence studies often pay $1,000–$5,000. Each study listing includes specific compensation details in the consent form.
What types of healthy volunteer studies are available in Brisbane, Queensland?
Common study types include Phase 1 drug safety trials, bioequivalence studies comparing generic and brand-name drugs, vaccine trials, dietary and nutrition studies, and observational research. All listed studies are registered on public registries and approved by ethics committees.
Do I need health insurance to participate?
No. Healthy volunteer studies cover all study-related medical costs. If an adverse event occurs, the trial sponsor is generally responsible for related treatment. Specifics are outlined in each study's informed consent document.